. 2022 Mar 10;12(6):2778–2789. doi: 10.1016/j.apsb.2022.03.001
© 2022 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences. Production and hosting by Elsevier B.V.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Figure 2.
NDDs drugs with specific mitochondrial targets.